Stock of the Day - September 22, 2022

Check-Cap (CHEK)

$1.62

+$0.04 (+2.2%)

Market Cap: $9.45M

About Check-Cap

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel.

Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.

Today's Trend

Check-Cap Ltd. (NASDAQ: CHEK) shares are trading higher, driven by a strategic merger announcement and increased market visibility from analyst coverage. While the company has seen multiple temporary trading halts under the LULD mechanism, investor focus remains on its upcoming combination with MBody AI and inclusion in penny-stock watchlists.

Check-Cap announced a merger agreement with MBody AI, sending its stock price sharply higher.Check-Cap jumps 120 percent on merger with MBody AI
Investors reacted to the merger terms, pushing the share price up substantially on the news.Check-Cap stock soars on merger agreement with MBody AI
TipRanks named Check-Cap as one of three penny stocks to watch on September 16, 2025, highlighting its potential catalysts.3 Penny Stocks to Watch Now, 9-16-25
Trading was temporarily halted multiple times on September 15 due to LULD pauses, indicating heightened volatility around the merger news.

← Previous Stock of the Day Next Stock of the Day →